Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
-
Canaccord Genuity Downgrades Imperial Metals Corp. (III:CN) (IPMLF) to Hold
-
Canaccord Genuity Downgrades First Quantum Minerals Ltd. (FM:CN) (FQVLF) to Hold
-
Director/PDMR Shareholding
-
Atalaya Mining PLC Announces First Quarter 2019 Operations Update
-
Perseus Mining Executes A$45 Million Underwriting Agreement for Warrants
-
Red Ventures Acquires HigherEducation.com
-
X4 Pharmaceuticals (XFOR) Prices 5.7M Shares at $11 w/Warrants
-
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
-
X4 Pharmaceuticals Inc. (XFOR) Announces Proposed Common Share and Class A Warrants Offering
-
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
-
Canaccord Genuity Resumes TMAC Resources (TMR:CN) (TMMFF) at Spec. Buy
-
Canaccord Genuity Downgrades PetroShale (PSH:CN) (PSHIF) to Spec. Buy
-
Troilus Announces C$12 Million Bought Deal Public Offering of Common Shares
-
NetworkNewsBreaks – Canaccord Genuity Issues ‘Speculative Buy’ Rating on Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
-
Cinedigm Digital Cinema (CIDM) PT Raised to $3 at Canaccord Genuity
-
Canaccord Genuity LLC Updates Report on Cinedigm, Reiterating Buy Rating and Increasing Price Target to $3.00
-
Canaccord Genuity LLC Updates Report on Cinedigm, Reiterating Buy Rating and Increasing Price Target to $3.00
-
Disclosure of Related Party Transaction
-
Dividend 15 Split Corp. Completes Overnight Offering of $56,489,950
-
Telaria Inc (TLRA) PT Raised to $9 at Canaccord Genuity
-
Aileron Therapeutics Inc (ALRN) PT Lowered to $5 at Canaccord Genuity
-
TransCanna meldet Abschluss seiner vermittelten Privatplatzierung von Anteilscheinen in Höhe von 16 Mio. CAD
-
Greenlane Launches Initial Public Offering
-
Sage Therapeutics (SAGE) KOL Call Takeaways - Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Totally Plc. ()
-
Canaccord Genuity Reiterates Hold Rating on Shaw Communications (SJRWF)
-
Sunniva Inc. (SNN:CN) (SNNVF) PT Lowered to Cdn$10 at Canaccord Genuity
-
MediPharm Labs Corp. (LABS:CN) (MLCPF) PT Raised to Cdn$5.50 at Canaccord Genuity
-
Aurora Cannabis Inc. (ACB:CN) (ACB) PT Raised to Cdn$13.50 at Canaccord Genuity
-
Canaccord Genuity Downgrades Southwest (LUV) to Hold
-
Histogenics (HSGX) to be Acquired by Ocugen
-
Canaccord Genuity Downgrades Obalon Therapeutics (OBLN) to Hold
-
Canaccord Genuity Upgrades Recipe Unlimited Corp. (RECP:CN) to Buy
-
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
-
Boeing's 737 production cut hits its shares and those of suppliers
-
Canaccord Genuity Downgrades Spirit AeroSystems (SPR) to Hold
-
Cubic Corp's (CUB) Transition Creates Opportunity - Canaccord
-
ProMetic Life Sciences (PLI:CN) (PFSCF) PT Lowered to Cdn$1 at Canaccord Genuity
-
CubeSmart (CUBE) PT Lowered to $70 at Canaccord Genuity
-
Ascendis Pharma (ASND) PT Raised to $133 at Canaccord Genuity
-
Canaccord Genuity Starts Goodfood Market (FOOD:CN) (GDDFF) at Spec. Buy
-
TransCanna Announces Closing of CDN$16 Million Brokered Private Placement of Units
-
TransCanna Announces Closing of CDN$16 Million Brokered Private Placement of Units
-
Ianthus Capital Holdings (IAN:CN) (ITHUF) PT Raised to Cdn$11 at Canaccord Genuity
-
Canaccord Genuity Starts Etsy (ETSY) at Buy
-
Atalaya Mining PLC Announces Results for the year ended 31 December 2018
-
10330698 Canada Ltd., Parent Company of Starbuds Canada & Compass Clinics, Strengthens Board with 3 New Independent Members
-
Okta, Inc (OKTA) PT Raised to $95 at Canaccord Genuity
-
Canaccord Genuity Downgrades Meridian Biosciences (VIVO) to Sell

